Following intraperitoneal injection of 3H-thymidine into host newts, iris together with a regenerating lens was transplanted from a donor eye into a lentectomized host eye at frequent intervals for 20 hours and then every 1 or 2 days for 14 days. The eyes were fixed 2 hours and 1 or 2 days after implantation and autoradiographs prepared. Following fixation 2 hours after operation, incorporation of 3H-thymidine into DNA, as evidenced by grain counts over nuclei, fell rapidly for 3.5 hours after injection and was no longer apparent after 4.5 hours. However, almost one-half of the implants were lightly labeled when they remained in the host eyes for 1 or 2 days beginning from 1 to 14 days after isotope injection. When these implanted, regenerating lenses were left in the host eyes for longer periods of time, then a light label was found over nuclei in most of the implants remaining in the eye for 3 to 24 days. When 3H-thymidine was injected from 1 to 3 days after extirpation of both lens and neural retina, before DNA synthesis had been initiated in the pigmented retinal epithelium or iris, there were numerous cases of labeled nuclei among depigmenting cells of the pigmented retinal epithelium which was regenerating a new neural retina from 2 to 25 days after isotope injection. Depigmenting cells of the dorsal iris and regenerating lens were similarly labeled. These results provide evidence for the continued availability of small amounts of tritiated DNA-precursor molecules which can be incorporated in DNA of proliferating cells long after the initial injection of 3H-thymidine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jez.1402260113 | DOI Listing |
Reprod Fertil Dev
February 2021
Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Ovarian hormones drive invivo generation of regulatory T cells (Tregs) during pregnancy. Little is known about the therapeutic potential of invitro hormone-derived Tregs in pregnancy loss. We investigated the effects of hormone-induced Tregs in a murine model of abortion.
View Article and Find Full Text PDFStem Cell Res Ther
May 2020
INSERM UMR-S-MD 1197/Ministry of the Armed Forces, Biomedical Research Institut of the Armed Forces (IRBA), Paul-Brousse Hospital Villejuif and CTSA Clamart, Clamart, France.
Background: Cardiovascular diseases are the main cause of morbidity and mortality worldwide. Restoring blood supply to ischemic tissues is an essential goal for the successful treatment of these diseases. Growth factor or gene therapy efficacy remains controversial, but stem cell transplantation is emerging as an interesting approach to stimulate angiogenesis.
View Article and Find Full Text PDFAllergy Asthma Proc
March 2018
Division of Rheumatology, Milton S. Hershey Medical Center at Penn State University, Hershey PA, USA.
Background: Allergic and autoimmune diseases comprise a group of inflammatory disorders caused by aberrant immune responses in which CD25+ Forkhead box P3-positive (FOXP3+) T regulatory (Treg) cells that normally suppress inflammatory events are often poorly functioning. This has stimulated an intensive investigative effort to find ways of increasing Tregs as a method of therapy for these conditions. One such line of investigation includes the study of how ligation of Toll-like receptors (TLRs) by CpG oligonucleotides (ODN) results in an immunostimulatory cascade that leads to induction of T-helper (Th) type 1 and Treg-type immune responses.
View Article and Find Full Text PDFCurr Cancer Drug Targets
October 2019
Instituto de Biología y Medicina Experimental (IBYME), CONICET, Buenos Aires, Argentina.
Background: Endocrine resistance and metastatic dissemination comprise major clinical challenges for breast cancer treatment. The fibroblast growth factor receptor family (FGFR) consists of four tyrosine kinase transmembrane receptors, involved in key biological processes. Genomic alterations in FGFR have been identified in advanced breast cancer and thus, FGFR are an attractive therapeutic target.
View Article and Find Full Text PDFAnticancer Agents Med Chem
October 2017
6, Pedro Meylan, 1208 Geneva. Switzerland.
Background: A DNA-RNA-lipoprotein complex, termed as virtosome, is released spontaneously from healthy human, other mammalian, avian, amphibian and plant cells in a regulated and energy-dependent manner. Studies on human and mouse lymphocytes, hepatocytes, NIH 3T3 cells and mouse tumour cell lines have shown that virtosomes may be acting as inter-cellular messengers. In particular, virtosomes from non-dividing cells blocked 3H-thymidine incorporation into DNA in tumour cell lines.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!